CRISPR/Cas systems for genomic Editing, biochemical Sensing, Bioanalysis, and diagnostics

被引:0
|
作者
Baig, Mirza Muhammad Faran Ashraf [1 ]
Chair, Sek Ying [1 ]
Chien, Wai Tong [1 ]
机构
[1] Chinese Univ Hong Kong, Fac Med, Asia Pacific Genet & Genom Nursing Ctr, Nethersole Sch Nursing,Croucher Lab Human Genom, Hong Kong, Peoples R China
关键词
CRISPR/Cas systems; Bacterial immune system; Gene modifications; Novel bio-analysis techniques; Medical; environmental; and agricultural; applications; NUCLEIC-ACID; CAS SYSTEM; DELIVERY; COVID-19; TECHNOLOGY; OPTIMIZATION; CRISPR-CAS9; RECOGNITION; INHIBITION; EXPRESSION;
D O I
10.1016/j.microc.2024.112638
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) systems were known for the last few decades as genome editing tools. These CRISPR systems used Cas enzymes to edit genes by cutting/editing target DNA/RNA strands of specific sequences. The CRISPR/Cas systems were originally found in various species of archaea/bacteria which helped organisms to break foreign DNA/RNA to protect themselves from viral/bacterial attacks. Later, scientists further developed these CRISPR/Cas systems by attaching fluorophores/colorimetric reporters to the DNA probes in designing various bioanalytical approaches to target, cut, identify, and analyze different types of DNAs and RNAs in biological, and clinical samples. During the last decade, technically advanced, robust, and bioanalytical technologies of clinical importance derived from CRISPR/Cas systems were developed, and established, for instance, point of care testing (POCT) devices had been in the market such as CRISPR/Cas-based rapid lateral flow assays; rapid assay testing kits (RAT Kits such as for the detection of COVID19); colorimetric, fluorescence; or biosensing techniques for bioanalysis. These CRISPR/Cas-based techniques detected analytes with as low concentration as micromolar, nanomolar, picomolar, and even of attomole levels in the patient's blood, urine, nasal, buccal, or saliva samples as a breakthrough for the rapid diagnosis of diseases. Moreover, CRISPR/Cas technique-based diagnostic tools such as SHERLOCK (Specific High-sensitivity Enzymatic Reporter Un-Locking) and DETECTR (DNA Endonuclease Targeted CRISPR Trans-Reporter) enabled sensitive detection of nucleic acids in the variety of clinical and environmental samples. Thus, for programmable nature of CRISPR/Cas systems and for the tailored biosensing solution, these innovations in detections had successful applications in infectious disease diagnosis, and genetic testing, in addition to the environmental monitoring, microbial detections, food safety/agricultural implications, and crop production.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Ethics and Genomic Editing Using the Crispr-Cas9 Technique: Challenges and Conflicts
    Lorenzo, David
    Esquerda, Montse
    Palau, Francesc
    Cambra, Francisco J.
    NANOETHICS, 2022, 16 (03) : 313 - 321
  • [22] Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing
    Kim, Dongyoon
    Quoc-Viet Le
    Wu, Yina
    Park, Jinwon
    Oh, Yu-Kyoung
    PHARMACEUTICS, 2020, 12 (12) : 1 - 42
  • [23] Advances in CRISPR-Cas systems for RNA targeting, tracking and editing
    Wang, Fei
    Wang, Lianrong
    Zou, Xuan
    Duan, Suling
    Li, Zhiqiang
    Deng, Zixin
    Luo, Jie
    Lee, Sang Yup
    Chen, Shi
    BIOTECHNOLOGY ADVANCES, 2019, 37 (05) : 708 - 729
  • [24] CRISPR-Cas systems: ushering in the new genome editing era
    Rojo, Fernando Perez
    Nyman, Rikard Karl Martin
    Johnson, Alexander Arthur Theodore
    Navarro, Maria Pazos
    Ryan, Megan Helen
    Erskine, William
    Kaur, Parwinder
    BIOENGINEERED, 2018, 9 (01) : 214 - 221
  • [25] Development of CRISPR/Cas Delivery Systems for In Vivo Precision Genome Editing
    Chen, Yuxuan
    Ping, Yuan
    ACCOUNTS OF CHEMICAL RESEARCH, 2023, 56 (16) : 2185 - 2196
  • [26] Exploiting CRISPR-Cas immune systems for genome editing in bacteria
    Barrangou, Rodolphe
    van Pijkeren, Jan-Peter
    CURRENT OPINION IN BIOTECHNOLOGY, 2016, 37 : 61 - 68
  • [27] CRISPR-Cas-mediated diagnostics
    Li, Luoxi
    Shen, Guanwang
    Wu, Min
    Jiang, Jianxin
    Xia, Qingyou
    Lin, Ping
    TRENDS IN BIOTECHNOLOGY, 2022, 40 (11) : 1326 - 1345
  • [28] Characterization of Cas proteins for CRISPR-Cas editing in streptomycetes
    Yeo, Wan Lin
    Heng, Elena
    Tan, Lee Ling
    Lim, Yi Wee
    Lim, Yee Hwee
    Hoon, Shawn
    Zhao, Huimin
    Zhang, Mingzi M.
    Wong, Fong Tian
    BIOTECHNOLOGY AND BIOENGINEERING, 2019, 116 (09) : 2330 - 2338
  • [29] Generation of inducible oncogenic chromosomal translocations using CRISPR-Cas9 genomic editing
    Spraggon, Lee
    Martelotto, Luciano
    Hmeljak, Julija
    Slotkin, Emily
    Wang, Lu
    Reis-Filho, Jorge
    Landanyi, Marc
    CANCER RESEARCH, 2016, 76
  • [30] PAM multiplicity marks genomic target sites as inhibitory to CRISPR-Cas9 editing
    Malina, Abba
    Cameron, Christopher J. F.
    Robert, Francis
    Blanchette, Mathieu
    Dostie, Josee
    Pelletier, Jerry
    NATURE COMMUNICATIONS, 2015, 6